Validity of serum amyloid A and HMGB1 as biomarkers for early diagnosis of gastric cancer

Ali A. Ghweil,Heba A. Osman,Mohammed H. Hassan,Abeer M. M. Sabry,Reem Ezzat Mahdy,Ahmed R. H. Ahmed,Ahmed Okasha,Ashraf Khodeary,Hesham H. Ameen

Validity of serum amyloid A and HMGB1 as biomarkers for early diagnosis of gastric cancer

2020

Ali A. Ghweil
Heba A. Osman
Mohammed H. Hassan
Abeer M. M. Sabry
Reem Ezzat Mahdy
Ahmed R. H. Ahmed
Ahmed Okasha
Ashraf Khodeary
Hesham H. Ameen

Background and aim Gastric carcinomais a frequent neoplasm with poor outcome, and its early detection would improve prognosis. This study was designed to evaluate the possible use of new biomarkers, namely SAA and HMGB1, for early diagnosis of gastric cancer.

Keywords:

HMGB1
Cancer
Internal medicine
Biomarker (medicine)
Oncology
Serum amyloid A
Medicine
Neoplasm
Gastric mucosa
Chronic gastritis
Gastritis
Gastroenterology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations